Natural antisense transcript to CARD8

The ENSG00000268583 locus encodes a long non-coding RNA that is transcribed from the opposite DNA strand to the CARD8 protein-coding gene. These natural antisense transcripts can regulate the expression of their sense counterparts via several mechanisms, such as interfering with transcription, masking regulatory sequences on mRNA, or forming double-stranded RNA that can affect stability or lead to gene silencing. While these transcripts are widespread and often play regulatory roles, this specific antisense RNA is not a receptor, enzyme, or other traditional drug target; its functional characterization remains incomplete. The name is descriptive rather than canonical, and this NAT is best considered as a genomic regulatory element rather than a protein or conventional therapeutic target[1][4].\n\nAdditional notes:\n- The designation "novel transcript, antisense to CARD8" is a placeholder from annotation pipelines and does not refer to a canonical protein or well-studied therapeutic target. It signifies an identified transcript opposite to the CARD8 gene that has not been further functionally or clinically characterized[4]. \n- NATs are increasingly recognized for their roles in gene regulation, but the specific function of this transcript remains uncharacterized, and it is not commonly cited as a druggable target or used for biomarker purposes in clinical settings.\n\nIn summary, ENSG00000268583 codes for a non-coding, regulatory antisense transcript related to the CARD8 gene, and is not considered a canonical drug target, receptor, or enzyme[4].

Other names

ENSG00000268583antisense to CARD8CARD8-AS

Not drug-related; mechanisms can include:\n- Transcriptional interference\n- RNA duplex formation affecting mRNA stability or translation\n- Chromatin state modification[1][4]